Lord, Abbett & Co. LLC Cytokinetics Inc Transaction History

Lord, Abbett & Co. LLC

$31.4 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 07, 2024	SELL	$63.75 - $108.06 $89.9 Million - $152 Million	-1,409,654 Reduced 87.68%	198,158 $13.9 Million
Q1 2024 May 09, 2024	SELL	$63.75 - $108.06 $89.9 Million - $152 Million	-1,409,654 Reduced 87.68%	198,158 $13.9 Million
Q4 2023 Oct 07, 2024	BUY	$26.88 - $83.49 $27.1 Million - $84 Million	1,006,641 Added 167.45%	1,607,812 $134 Million
Q4 2023 Feb 12, 2024	BUY	$26.88 - $83.49 $27.1 Million - $84 Million	1,006,641 Added 167.45%	1,607,812 $134 Million
Q3 2023 Oct 07, 2024	SELL	$29.46 - $36.61 $32.1 Million - $39.9 Million	-1,089,299 Reduced 64.44%	601,171 $17.7 Million
Q3 2023 Nov 13, 2023	SELL	$29.46 - $36.61 $32.1 Million - $39.9 Million	-1,089,299 Reduced 64.44%	601,171 $17.7 Million
Q2 2023 Oct 07, 2024	SELL	$32.62 - $40.75 $20.1 Million - $25.1 Million	-616,799 Reduced 26.73%	1,690,470 $55.1 Million
Q2 2023 Aug 14, 2023	SELL	$32.62 - $40.75 $20.1 Million - $25.1 Million	-616,799 Reduced 26.73%	1,690,470 $55.1 Million
Q1 2023 Oct 07, 2024	SELL	$33.36 - $45.71 $20.6 Million - $28.2 Million	-617,042 Reduced 21.1%	2,307,269 $81.2 Million
Q1 2023 May 12, 2023	SELL	$33.36 - $45.71 $20.6 Million - $28.2 Million	-617,042 Reduced 21.1%	2,307,269 $81.2 Million
Q4 2022 Oct 07, 2024	BUY	$35.77 - $51.11 $105 Million - $149 Million	2,924,311 New	2,924,311 $134 Million
Q4 2022 Feb 10, 2023	SELL	$35.77 - $51.11 $29.8 Million - $42.6 Million	-834,311 Reduced 22.2%	2,924,311 $134 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $29.6 Million - $41.9 Million	768,471 Added 25.7%	3,758,622 $182 Million
Q2 2022 Aug 12, 2022	BUY	$33.93 - $48.92 $24.8 Million - $35.8 Million	732,147 Added 32.42%	2,990,151 $117 Million
Q1 2022 May 13, 2022	BUY	$29.74 - $46.0 $42.4 Million - $65.5 Million	1,424,936 Added 171.05%	2,258,004 $83.1 Million
Q4 2021 Feb 11, 2022	BUY	$34.35 - $46.38 $28.6 Million - $38.6 Million	833,068 New	833,068 $38 Million

Others Institutions Holding CYTK

# of Institutions

409

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

Black Rock Inc. New York, NY

14.7M
Shares

$717 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$575 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

9.69M
Shares

$474 Million
0.31% of portfolio
Wellington Management Group LLP Boston, MA

7.77M
Shares

$380 Million
0.07% of portfolio
State Street Corp Boston, MA

6.46M
Shares

$316 Million
0.01% of portfolio

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.6B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account